Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

4
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsSector news 

Photocure ASA : Mandatory notification of trade

03/22/2013 | 05:02am US/Eastern
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

distributed by
React to this article
Latest news on PHOTOCURE ASA
1d ago PHOTOCURE ASA : Focus on Cevira®: Review article published in Expert Opinion of ..
11/28 PHOTOCURE ASA : Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nur..
11/06 PHOTOCURE ASA : Results for third quarter and the first nine months 2014
10/30 PHOTOCURE ASA : Cevira® featured in the Nolato Magazine
10/10 PHOTOCURE ASA : Results of the Cevira phase 2b presented at DGGG
09/23 PHOTOCURE ASA : Expert consensus on the optimal use of Cysview® Blue-Light Cysto..
09/12 PHOTOCURE ASA : Cysview Optical Imaging Agent Sought by Health and Human Service..
09/04 PHOTOCURE ASA : Presolicitation Notice - Cysview (Hexaminolevulinate Hydrocholri..
08/26 PHOTOCURE ASA : Results for second quarter and the first half year 2014
08/18 PHOTOCURE ASA : Presentation of the second quarter 2014 results
Advertisement
Chart
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF